- $35.89m
- $118.72m
- CNY12.56bn
Brief: 111 To Be The Omni-Channel Drug Commercialization Partner Of Xiangxu Pharmaceutical For Traditional Chinese Medicine
Brief: 111, Inc. And Shanghai Uniondrug Information Technology Join Hands To Advance Innovation In Commercial Insurance Payment
Brief: 111 Inc Partners With Baiyunshan Pharmaceutical Sales In Digital Medicine Innovation
Brief: 111 Inc Reports Qtrly Net Revenues Of RMB 1.62 Bln
Brief: 111, Inc Announces Strategic Plan To Expand Access To China's Capital Markets
Brief: 111 Inc Launches Lung Cancer Patient Care Program For Full Life-Cycle Management Of Tumor
Brief: 111 Launched The Overseas Direct Delivery Service
Brief: 111 And Wenjiang People's Hospital To Build Online Cancer Diagnosis And Treatment Platform
Brief: 111 Launches Free Consultation Services For Chinese Citizens Abroad Against COVID-19
Brief: 111 Sees Q1 Revenue Up About 113.5% To 125.7%
Brief: 111 Inc Announced Strategic Partnership With Winhealth Pharma Group
Brief: 111 Inc Entered Strategic Partnership With Bestyoo
NASDAQ RESUMED AT 02:54 PM
NASDAQ RESUMED AT 02:27 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:21 PM
U.S. STOCKS ON THE MOVE-Rite Aid, Red Robin Gourmet Burgers, Tesla, Five Star Senior Living
Brief: Tianjin Tongrentang Group Partners With Online Pharmacy Giant 111
Brief: 111, Inc Reports Qtrly Non-GAAP Loss Per ADS Of $0.19
Brief: 111 Signs Strategic Partnership With Hec Group To Strengthen Cooperation With Innovative Pharmaceutical Manufacturer